COVID-19

US STUDY: COVID-19 Does Not Pose A Threat To Blood And Transfusion Safety
Clinical News

US STUDY: COVID-19 Does Not Pose A Threat To Blood And Transfusion Safety

A new reassuring US study, published recently in the journal Transfusion, suggests that the risk of transmission of SARS-CoV2 through blood transfusion is highly unlikely. For the study, the investigators…
Chinese Sinovac COVID-19 Vaccine Approved By World Health Organization
Clinical News

Chinese Sinovac COVID-19 Vaccine Approved By World Health Organization

The World Health Organization (WHO) announced yesterday that it has approved a COVID-19 vaccine made by Sinovac Biotech (SVA.O) for emergency use listing, paving the way for a second Chinese shot…
TIF Declares Support For Patent Waiver On COVID-19 Vaccines
TIF News (AR)

TIF Declares Support For Patent Waiver On COVID-19 Vaccines

In the midst of the raging COVID-19 pandemic, US President Joe Biden openly supported the World Trade Organization’s (WTO) proposal to lift the proprietary limits on COVID-19 vaccines, in service…
New Paper From Blood and Beyond Outlines How To Learn From The Impact Of The COVID-19 Crisis On Blood Use
TIF News (AR)

New Paper From Blood and Beyond Outlines How To Learn From The Impact Of The COVID-19 Crisis On Blood Use

The multi-stakeholder Blood and Beyond initiative recently published a policy briefing shedding light on how the COVID-19 pandemic affects blood use, blood transfusion services, and patients in whom transfusions are…
Blood Donors’ COVID-19 Antibodies: Do They Have A Positive Significance for Blood Recipients?
TIF News (AR)

Blood Donors’ COVID-19 Antibodies: Do They Have A Positive Significance for Blood Recipients?

According to recent data released by the American Red Cross, in the first week of March 2021 more than 20% of blood donations from unvaccinated people in the US had…
COMING UP: New TIF Webinar On ”COVID-19 Vaccinations & Patients With Haemoglobin Disorders”
TIF News (AR)

COMING UP: New TIF Webinar On ”COVID-19 Vaccinations & Patients With Haemoglobin Disorders”

TIF is delighted to inform you that a Special Webinar on ‘’COVID-19 Vaccinations & Patients with Haemoglobin Disorders’’ will take place on Wednesday, 31 March 2021, at 14:30-16:00 EEST/12:30-14:00 GMT.…
Out Now: The Latest Issue of TIF’s COVID-19 Vaccinations Update
TIF News (AR)

Out Now: The Latest Issue of TIF’s COVID-19 Vaccinations Update

Everything you need to know about the different COVID-19 vaccines, both already available and developing, in one place! Discover our newly updated Guide ”Vaccinations & Therapeutic Drugs for COVID-19”, containing a…
The Lancet: Russian Coronavirus Sputnik V Vaccine Achieves Over 90% Efficacy
Clinical News

The Lancet: Russian Coronavirus Sputnik V Vaccine Achieves Over 90% Efficacy

Russia’s Sputnik V vaccine was 91.6% effective in preventing people from developing Covid-19, according to peer-reviewed results from its late-stage clinical trial published yesterday in The Lancet international medical journal.…
TIF Updated Vaccinations & Therapeutic Drugs COVID-19 Guide Has Landed
أخبار

TIF Updated Vaccinations & Therapeutic Drugs COVID-19 Guide Has Landed

A comprehensive Guide for both existing and developing vaccines and treatments against COVID-19, exclusively developed by TIF for its global thalassaemia community. Featuring: Pfizer, Moderna, AstraZeneca: What are the differencies…
زر الذهاب إلى الأعلى